Chorba T L, Holman R C, Clarke M J, Evatt B L
Division of Immunologic, Oncologic, and Hematologic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, Atlanta, Georgia, USA.
Am J Hematol. 2001 Apr;66(4):229-40. doi: 10.1002/ajh.1050.
Because of changes in factor replacement therapy and in treatment of human immunodeficiency virus (HIV) infection, we examined death record data for persons with hemophilia A in the United States to evaluate effects of HIV infection on age and causes of death. Multiple cause-of-death data from 1968 through 1998 were examined to assess death rates for persons with hemophilia A. ICD-9 coded causes of death from 1979 through 1998 were examined to assess long-term trends. From 1979 through 1998, 4,781 deaths among persons with hemophilia A were reported, of which 2,254 (47%) had HIV-related disease listed as a cause of death. In the late 1980s, mortality among persons with hemophilia A increased markedly, and the age-adjusted death rate peaked at 1.5 per 1,000,000 population in 1992. Median age at death decreased from 55 years in 1979-1982 to 40.5 years in 1987-1990, and increased to 46 years in 1995-1998. In the period 1995-1998, the median age of hemophilia A decedents with HIV-related disease was 33 years, compared to 72 years for those without HIV-related disease; the most frequently listed causes of death for those without HIV-related disease were hemorrhagic and circulatory phenomena; the most frequently listed for those with HIV-related disease were diseases of liver and the respiratory system. From 1995 to 1998, hemophilia A-associated deaths decreased by 41%, with a 78% decrease among those who had HIV-related disease. Although HIV infection has adversely effected mortality for persons with hemophilia A, the marked recent decrease in the death rate among persons with hemophilia A appears to reflect advances in care for those with HIV-related disease and is consistent with a decline in HIV mortality observed in the general population.
由于凝血因子替代疗法以及人类免疫缺陷病毒(HIV)感染治疗方法的变化,我们查阅了美国甲型血友病患者的死亡记录数据,以评估HIV感染对年龄和死因的影响。研究了1968年至1998年的多重死因数据,以评估甲型血友病患者的死亡率。研究了1979年至1998年国际疾病分类第九版(ICD-9)编码的死因,以评估长期趋势。1979年至1998年期间,报告了4781例甲型血友病患者死亡,其中2254例(47%)将与HIV相关的疾病列为死因。在20世纪80年代后期,甲型血友病患者的死亡率显著上升,年龄调整后的死亡率在1992年达到每100万人口1.5例的峰值。死亡年龄中位数从1979 - 1982年的55岁降至1987 - 1990年的40.5岁,并在1995 - 1998年升至46岁。在1995 - 1998年期间,患有与HIV相关疾病的甲型血友病死者的年龄中位数为33岁,而无HIV相关疾病者为72岁;无HIV相关疾病者最常列出的死因是出血和循环系统疾病;有HIV相关疾病者最常列出的死因是肝脏疾病和呼吸系统疾病。1995年至1998年,与甲型血友病相关的死亡人数减少了41%,其中患有与HIV相关疾病者减少了